Navigation Links
Fish Oil Helped Stave Off Psychosis in Study Patients
Date:2/2/2010

Supplements may benefit those at high risk of schizophrenia

TUESDAY, Feb. 2 (HealthDay News) -- Among people at high risk of developing schizophrenia and other psychotic disorders, fish oil may help reduce their risk, researchers have found.

The new study included 81 high-risk patients with either mild psychotic symptoms, transient psychosis or a family history of psychotic disorders, plus a decrease in daily functioning. These criteria identify people whose risk of becoming psychotic may be as high as 40 percent in a one-year period.

For 12 weeks, 41 participants were assigned to take daily fish oil capsules containing 1.2 grams of omega-3 polyunsaturated fatty acids and 40 were given a placebo. Of the 76 patients who completed the study, two (4.9 percent) in the fish oil group and 11 (27.5 percent) in the placebo group progressed to psychosis, a difference of 22.6 percent, the researchers found.

Based on these results, Dr. G. Paul Amminger of Medical University of Vienna in Austria and the Orygen Youth Health Research Center in Melbourne, Australia, and colleagues estimated that four adults would have to take fish oil with omega-3 fatty acids to prevent one of them from developing psychosis over a one-year period.

In their report, published in the February issue of the Archives of General Psychiatry, the study authors also noted that patients who took the fish oil capsules had fewer symptoms of psychosis and better functioning than those who took the placebo.

The beneficial effects of fish oil capsules with omega-3 fatty acids may result from changes in cell membranes and interactions with neurotransmitter systems in the brain, the researchers explained in a news release from the journal's publisher.

Amminger and colleagues noted that many young adults are reluctant to take antipsychotic drugs due to perceived stigma and side effects such as sexual dysfunction, metabolic changes and weight gain. Omega-3 fatty acids may offer an natural alternative.

"Long-chain omega-3 fatty polyunsaturated fatty acids reduce the risk of progression to psychotic disorder and may offer a safe and efficacious strategy for indicated prevention in young people with subthreshold psychotic states," the authors concluded.

More information

Mental Health America has more about schizophrenia.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Feb. 1, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. More than 6 Million Helped by Partnership for Prescription Assistance
2. Crohn's & Colitis Foundation Encourages More Virtual Event Participants: Thousands Already Helped Foundation Raise Funds for Research & Support Legislation
3. Topical Spray Helped Men With Premature Ejaculation
4. Grapefruit-Heavy Diet Helped Spur Dangerous Clot
5. Clinical Data from Plastic Surgeon in New Jersey Helped in Final Determination of 2008's Top Plastic Surgery Procedures
6. AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008
7. Pre-emptive treatment helped curtail skin toxicity with panitumumab
8. Elderlys restless nights helped by ancient martial art
9. Researchers who helped millions with arthritis receive prestigious Janssen Award
10. Insights on Paying for Boomers Care Needs in 20-40 Years Helped by New Report
11. First-Time Shoulder Dislocations Helped by Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... September 26, 2017 , ... Atmosera , a ... Management as a Service (RMaaS) to automate the deployment of websites and ... companies, e-tailers, and web development agencies who want to improve time-to-revenue with a ...
(Date:9/26/2017)... ... , ... As the holiday season nears, best deals online website, ... to find tips and stories for products and services savings. With a lot of ... deals. The deals are organized by categories so can easily find what you’re looking ...
(Date:9/26/2017)... Falls Church, VA (PRWEB) , ... September 26, 2017 , ... ... FDAnews and Cerulean Associates LLC **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity ... its investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy ...
(Date:9/26/2017)... ... September 26, 2017 , ... Autism Learning ... Northern Colorado. Aspire Autism, A Division of Autism Learning Partners, will be the ... Aspire provides center based Autism services in Broomfield and will continue to operate ...
(Date:9/26/2017)... ... September 26, 2017 , ... The Organizing Committee ... tactical plans for Pittcon 2018. As of July 1, Adrian C. Michael, Ph.D. ... named vice president, Charles Gardner, (ChemImage Corporation) and selected chairs. , ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), the ... and tissue hypothermic storage and cryopreservation freeze ... and CEO, will be presenting at two investment conferences in ... th Annual Global Investment Conference on Tuesday, September 12th, ... conference is being held at the New York Palace Hotel ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: